TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $919,119 | +79.7% | 59,413 | +82.4% | 0.00% | +100.0% |
| Q2 2023 | $511,580 | -1.2% | 32,564 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $517,884 | -9.1% | 31,425 | -14.0% | 0.00% | -33.3% |
| Q4 2022 | $569,884 | +175.3% | 36,531 | +128.9% | 0.00% | +200.0% |
| Q3 2022 | $207,000 | +19.0% | 15,958 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | +43.8% | 12,405 | +47.1% | 0.00% | 0.0% |
| Q1 2022 | $121,000 | -43.2% | 8,434 | -45.9% | 0.00% | 0.0% |
| Q4 2021 | $213,000 | +69.0% | 15,601 | +102.1% | 0.00% | 0.0% |
| Q3 2021 | $126,000 | -14.9% | 7,720 | -12.3% | 0.00% | 0.0% |
| Q2 2021 | $148,000 | 0.0% | 8,804 | +8.6% | 0.00% | -50.0% |
| Q1 2021 | $148,000 | +33.3% | 8,107 | +32.4% | 0.00% | +100.0% |
| Q4 2020 | $111,000 | +50.0% | 6,122 | +45.6% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | +37.0% | 4,204 | +37.7% | 0.00% | 0.0% |
| Q2 2020 | $54,000 | – | 3,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |